Terms: = Kidney tumors AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Treatment
34 results:
1. treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
Atkins MB; Jegede OA; Haas NB; Mcdermott DF; Bilen MA; Stein M; Sosman J; Alter R; Plimack ER; Ornstein MC; Hurwitz M; Peace DJ; Einstein D; Catalano PJ; Hammers H; Regan MM
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604810
[TBL] [Abstract] [Full Text] [Related]
2. The novel CDK9 inhibitor, XPW1, alone and in combination with brd4 inhibitor JQ1, for the treatment of clear cell renal cell carcinoma.
Kuang Z; Guo K; Cao Y; Jiang M; Wang C; Wu Q; Hu G; Ao M; Huang M; Qin J; Zhao T; Lu S; Sun C; Li M; Wu T; Liu W; Fang M
Br J Cancer; 2023 Dec; 129(12):1915-1929. PubMed ID: 37884683
[TBL] [Abstract] [Full Text] [Related]
3. Greening microwave-assisted digestion method using hydrogen peroxide for determination of elemental impurities by ICP-OES in antihypertensive active pharmaceutical ingredients.
Senger CM; Dornelles IS; Queiroz JM; Mello PA; Muller EI; Muller ALH
J Pharm Biomed Anal; 2024 Jan; 238():115802. PubMed ID: 37871418
[TBL] [Abstract] [Full Text] [Related]
4. An International Survey of Genitourinary and Renal Pathologists Regarding Evaluation of the Non-Neoplastic Parenchyma in kidney Cancer Specimens.
Paik J; Ellis CL; Henriksen KJ; Chang A
Int J Surg Pathol; 2024 Apr; 32(2):273-278. PubMed ID: 37226477
[TBL] [Abstract] [Full Text] [Related]
5. BET-HDAC Dual Inhibitors for Combinational treatment of Breast Cancer and Concurrent Candidiasis.
Huang Y; Liu N; Pan Z; Li Z; Sheng C
J Med Chem; 2023 Jan; 66(2):1239-1253. PubMed ID: 36622852
[TBL] [Abstract] [Full Text] [Related]
6. Deregulation of SPOP in Cancer.
Zhang H; Jin X; Huang H
Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
[TBL] [Abstract] [Full Text] [Related]
7. capsaicin inhibits the migration, invasion and EMT of renal cancer cells by inducing AMPK/mTOR-mediated autophagy.
Que T; Ren B; Fan Y; Liu T; Hou T; Dan W; Liu B; Wei Y; Lei Y; Zeng J; Li L
Chem Biol Interact; 2022 Oct; 366():110043. PubMed ID: 36044967
[TBL] [Abstract] [Full Text] [Related]
8. Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma.
Liu Z; Lin D; Zhou Y; Zhang L; Yang C; Guo B; Xia F; Li Y; Chen D; Wang C; Chen Z; Leng C; Xiao Z
Sci Rep; 2022 Aug; 12(1):13222. PubMed ID: 35918352
[TBL] [Abstract] [Full Text] [Related]
9. Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019.
Certan M; Garcia Garrido HM; Wong G; Heijmans J; Grobusch MP; Goorhuis A
Clin Infect Dis; 2022 Sep; 75(6):1046-1053. PubMed ID: 35195716
[TBL] [Abstract] [Full Text] [Related]
10.
Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
[TBL] [Abstract] [Full Text] [Related]
11. Clinical, Radiographic, Pathologic Characterization and Survival Outcomes of Nuclear Protein of the Testis Carcinoma.
Virarkar M; Mallery M; Saleh M; Ramani NS; Morani AC; Bhosale P
J Comput Assist Tomogr; 2021 May-Jun 01; 45(3):431-441. PubMed ID: 34297512
[TBL] [Abstract] [Full Text] [Related]
12. Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus.
Tan WP; Rastinehad AR; Klotz L; Carroll PR; Emberton M; Feller JF; George AK; Gill IS; Gupta RT; Katz AE; Lebastchi AH; Marks LS; Marra G; Pinto PA; Song DY; Sidana A; Ward JF; Sanchez-Salas R; Rosette J; Polascik TJ;
Urol Oncol; 2021 Nov; 39(11):781.e17-781.e24. PubMed ID: 33676851
[TBL] [Abstract] [Full Text] [Related]
13. Management of Very Late Pancreatic Metastasis of Renal Cell Carcinoma 8 Years After Radical Nephrectomy: A Report of a Rare Case.
Alayyaf N; AlQatari AA; Altalib A; AlQattan AS; Alshahrani AA
Am J Case Rep; 2021 Jan; 22():e927921. PubMed ID: 33400693
[TBL] [Abstract] [Full Text] [Related]
14. Combination immunotherapy of oncolytic virus nanovesicles and PD-1 blockade effectively enhances therapeutic effects and boosts antitumour immune response.
Ji W; Li L; Zhou S; Qiu L; Qian Z; Zhang H; Zhao P
J Drug Target; 2020 Nov; 28(9):982-990. PubMed ID: 32379004
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of brd4 prevents proliferation and epithelial-mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis.
Tan YF; Wang M; Chen ZY; Wang L; Liu XH
Cell Death Dis; 2020 Apr; 11(4):239. PubMed ID: 32303673
[TBL] [Abstract] [Full Text] [Related]
16. Bromodomain-containing protein 4 contributes to renal fibrosis through the induction of epithelial-mesenchymal transition.
Wang X; Zhou Y; Peng Y; Huang T; Xia F; Yang T; Duan Q; Zhang W
Exp Cell Res; 2019 Oct; 383(2):111507. PubMed ID: 31356816
[TBL] [Abstract] [Full Text] [Related]
17. Bromodomain-Containing Protein 4 (brd4) Inhibition Sensitizes Palomid 529-Induced Anti-Renal Cell Carcinoma Cell Activity in Vitro and in Vivo.
Xing ZY; Wang Y; Cheng L; Chen J; He XZ; Xing W
Cell Physiol Biochem; 2018; 50(2):640-653. PubMed ID: 30308518
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of brd4 Suppresses Cell Proliferation and Induces Apoptosis in Renal Cell Carcinoma.
Wu X; Liu D; Gao X; Xie F; Tao D; Xiao X; Wang L; Jiang G; Zeng F
Cell Physiol Biochem; 2017; 41(5):1947-1956. PubMed ID: 28391274
[TBL] [Abstract] [Full Text] [Related]
19. Prostate cancer in renal transplant recipients.
Sherer BA; Warrior K; Godlewski K; Hertl M; Olaitan O; Nehra A; Deane LA
Int Braz J Urol; 2017; 43(6):1021-1032. PubMed ID: 28338305
[TBL] [Abstract] [Full Text] [Related]
20. Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: A survey of U.S. transplantation centers.
Gin GE; Pereira JF; Weinberg AD; Mehrazin R; Lerner SM; Sfakianos JP; Phillips CK
Urol Oncol; 2016 Feb; 34(2):57.e9-13. PubMed ID: 26433443
[TBL] [Abstract] [Full Text] [Related]
[Next]
